| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.18 | 0.0009 |